The Company was formed in 2022 and Currently under the Developmental Stage with the R & D Works Going on. Veta Genomics also provides a Platform for the Exploration of Next Generation Sequencing Technologies and Advanced Molecular Techniques. The Firm also provides a Platform for the exploration of new Valuable Bioscience Projects and Services at our Facility.